Assessment of Biological Variation and Analytical Imprecision of CA 125, CEA, and TPA in Relation to Monitoring of Ovarian Cancer

Author： Tuxen M.K. Soletormos G. Petersen P.H. Schioler V. Dombernowsky P.

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.74, Iss.1, 1999-07, pp. : 12-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Value of CA125, CA19-9, CEA, CA72-4, and TPA in Borderline Ovarian Tumor

By Tamakoshi K. Kikkawa F. Shibata K. Tomoda K. Obata N.H. Wakahara F. Tokuhashi Y. Ishikawa H. Kawai M. Tomoda Y.

Gynecologic Oncology, Vol. 62, Iss. 1, 1996-07 ,pp. : 67-72

Academic Press

Access to resources Recommend Favorite

Role of HE4, CA72.4, and CA125 in monitoring ovarian cancer

By Granato Teresa

Tumor Biology, Vol. 33, Iss. 5, 2012-10 ,pp. : 1335-1339

Springer Publishing Company

Access to resources Recommend Favorite

Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients

By Yamamoto Manabu Baba Hideo Toh Yasushi Okamura Takeshi Maehara Yoshihiko

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 7, 2007-07 ,pp. : 471-476

Springer Publishing Company

Access to resources Recommend Favorite

Effects of Paclitaxel on CA-125 Serum Levels in Ovarian Cancer Patients

By Paulsen T. Marth C. Kaern J. Nustad K. Kristensen G.B. Trope C.

Gynecologic Oncology, Vol. 76, Iss. 3, 2000-03 ,pp. : 326-330

Elsevier

Access to resources Recommend Favorite

Effect of Topotecan on Serum CA-125 in Patients with Advanced Epithelial Ovarian Cancer

By Nielsen H.A. Nielsen D. Engelholm S.A.

Gynecologic Oncology, Vol. 77, Iss. 3, 2000-06 ,pp. : 383-388

Elsevier

Access to resources Recommend Favorite